Ischemic optic neuropathy occurs when blood flow to the optic nerve is suddenly reduced, most often linked to underlying vascular risk factors such as high blood pressure and diabetes, which are increasingly common across Uganda. The resulting vision loss is typically sudden and painless. While managing the underlying vascular risk factors remains the medical priority, some Ugandan patients explore stem cell therapy as an additional option to help support the affected optic nerve.
Vascular risk factors linked to ischemic optic neuropathy — hypertension and diabetes — are widespread across Uganda, yet specialized neuro-ophthalmology evaluation for the resulting optic nerve damage is limited outside major cities. Patients are often referred abroad to explore regenerative options once their underlying vascular condition is under medical management.

Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience

Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience

Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
Suitability depends on the stage and cause of the condition. Before travelling, our team reviews:

I came from overseas specifically for treatment. The staff not only assisted me with transport but also made the whole experience hassle-free. The medical service was of the highest standard and I was very secure in Delhi.

Your family is very thankful to stem cell cure india for being there for us. The doctors were very understanding and the staff made it a point to see that we were comfortable during the treatment. It was a very calming experience
“No. Managing the underlying vascular risk factors remains essential and is handled by your treating physician. Stem cell therapy addresses the optic nerve tissue itself, not the underlying vascular condition.”
“Earlier evaluation generally allows a clearer picture of remaining optic nerve function, though our team can review reports at any stage.”
” OCT scan, visual field test, and recent blood pressure/diabetes records, along with details of when vision loss occurred.”

We would love to hear from you! Please fill out the form below.